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http://www.biomedcentral.com/1471-2199/15/3RESEARCH ARTICLE Open AccessSpdef deletion rescues the crypt cell proliferation
defect in conditional Gata6 null mouse small
intestine
Boaz E Aronson1,2, Kelly A Stapleton1, Laurens ATM Vissers3, Eva Stokhuijzen2, Hanneke Bruijnzeel2
and Stephen D Krasinski1*Abstract
Background: GATA transcription factors are essential for self-renewal of the small intestinal epithelium. Gata4 is
expressed in the proximal 85% of small intestine while Gata6 is expressed throughout the length of small intestine.
Deletion of intestinal Gata4 and Gata6 results in an altered proliferation/differentiation phenotype, and an up-regulation
of SAM pointed domain containing ETS transcription factor (Spdef), a transcription factor recently shown to act as a
tumor suppressor. The goal of this study is to determine to what extent SPDEF mediates the downstream functions of
GATA4/GATA6 in the small intestine. The hypothesis to be tested is that intestinal GATA4/GATA6 functions through
SPDEF by repressing Spdef gene expression. To test this hypothesis, we defined the functions most likely regulated by the
overlapping GATA6/SPDEF target gene set in mouse intestine, delineated the relationship between GATA6 chromatin
occupancy and Spdef gene regulation in Caco-2 cells, and determined the extent to which prevention of Spdef
up-regulation by Spdef knockout rescues the GATA6 phenotype in conditional Gata6 knockout mouse ileum.
Results: Using publicly available profiling data, we found that 83% of GATA6-regulated genes are also regulated by
SPDEF, and that proliferation/cancer is the function most likely to be modulated by this overlapping gene set. In
human Caco-2 cells, GATA6 knockdown results in an up-regulation of Spdef gene expression, modeling our mouse
Gata6 knockout data. GATA6 occupies a genetic locus located 40 kb upstream of the Spdef transcription start site,
consistent with direct regulation of Spdef gene expression by GATA6. Prevention of Spdef up-regulation in conditional
Gata6 knockout mouse ileum by the additional deletion of Spdef rescued the crypt cell proliferation defect, but had
little effect on altered lineage differentiation or absorptive enterocytes gene expression.
Conclusion: SPDEF is a key, immediate downstream effecter of the crypt cell proliferation function of GATA4/GATA6 in
the small intestine.
Keywords: GATA6, SPDEF, Crypt cell proliferation, Intestinal differentiationBackground
The mature mammalian small intestine is lined by a highly
specialized epithelium that regenerates itself in a tightly
controlled manner resulting in a lineage distribution and
gene expression patterning that is perfectly suited for the
absorption of nutrients. The epithelium is organized into
crypt-villus structures in which the Crypts of Lieberkühn
contain stem cells that produce proliferating, transit-* Correspondence: stephen.krasinski@childrens.harvard.edu
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unless otherwise stated.amplifying (TA) cells that differentiate into five principal
post-mitotic cell types comprised of one type of absorptive
cell (absorptive enterocytes) and four types of secretory
cells (enteroendocrine, goblet, Paneth, and tuft cells [1]).
Absorptive enterocytes express digestive enzymes and
transporters necessary for the terminal digestion and
absorption of nutrients. Mucus-secreting goblet cells
and defensin-secreting Paneth cells maintain a dynamic
mucosal defensive barrier. Enteroendocrine cells secrete
hormones that regulate gastrointestinal processes. Tuft
cells, recently shown to be an independent secretory lineage
[2], secrete opioids and produce enzymes that synthesizel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.biomedcentral.com/1471-2199/15/3prostaglandins, suggesting a role in inflammation. Absorp-
tive enterocytes, goblet cells, enteroendocrine cells, and
tuft cells migrate up the crypt to populate the villi, whereas
Paneth cells migrate to the base of crypts. The differenti-
ated cells eventually undergo apoptosis and are shed into
the lumen. Cells of the villus epithelium turn over in
3–4 days, whereas Paneth cells at the base of crypts turn
over at a slower rate of 3–6 weeks.
Current models of intestinal epithelial renewal suggest
that long-lived, multipotent stem cells produce progenitors
that undergo a series of transitions that ultimately give rise
to the individual cell lineages [1,3]. The Wnt, hedgehog,
and bone morphogenetic protein signaling pathways regu-
late intestinal proliferation and differentiation, while the
Notch signaling pathway plays a central role in determin-
ing epithelial cell fate. The first decision selects absorptive
vs. secretory progenitors. Activated Notch signaling re-
sults in the transcriptional activation of its principal
intestinal target, hairy and enhancer of split 1 (Hes1),
which encodes a transcription factor that selects the
absorptive enterocyte lineage. Progenitor cells that escape
Notch signaling and activation of Hes1 gene transcription
express atonal homolog 1 (Atoh1, formerly called Math1),
which encodes a transcription factor that selects the
secretory cells. Additional regulators that function in
secretory cell differentiation include: growth factor in-
dependent 1 (Gfi1) that distinguishes enteroendocrine
from goblet/Paneth progenitors; neurogenin 3 (Neurog3)
that specifies the enteroendocrine lineage; SAM pointed
domain-containing Ets transcription factor (Spdef), a GFI1
target, that promotes goblet differentiation; and SRY-box
containing gene 9 (Sox9) and ephrin type B receptor 3
(Ephb3), Wnt targets that are necessary for the differen-
tiation of Paneth cells and their localization to the crypt
base, respectively.
Recently, we showed that members of the GATA family,
an ancient family of transcription factors that bind WGA-
TAR motifs in DNA, play essential roles in crypt cell
proliferation, secretory cell differentiation, and absorptive
enterocyte gene expression. Gata4 and Gata6 are expressed
in the intestinal epithelium, but whereas Gata6 is expressed
throughout the length of the small intestine, Gata4 is
expressed in the proximal 85% of small intestine and is
sharply down-regulated in the distal ileum [4-6]. Using
conditional knockout technology, we [5,7] and others [8]
have shown that GATA4 functions to promote a ‘jejunal’
pattern of absorptive enterocyte gene expression and func-
tion while repressing an ‘ileal’ pattern. Using single and
double conditional knockout approaches for Gata4 and
Gata6, we found that in the ileum of single Gata6 con-
ditional knockout mice, where Gata4 is not normally
expressed, or throughout the small intestine of double
Gata4/Gata6 conditional knockout mice, crypt cell prolif-
eration and enteroendocrine cell specification are decreased,Paneth cells are replaced by a goblet-like cell type, and
the expression of specific absorptive enterocyte genes is
altered [4]. We also noted that Spdef, a transcription factor
expressed in secretory progenitors, goblet cells and Paneth
cells that functions in goblet and Paneth cell differentiation
[9,10], was up-regulated [4]. Using a conditional Spdef
over-expression model, Noah et al. [10] described an intes-
tinal phenotype that, with the exception of the changes in
absorptive enterocyte gene expression, essentially pheno-
copies that of our Gata4/Gata6 conditional knockout mice:
crypt cell proliferation is decreased, enteroendocrine and
Paneth cells are decreased, and goblet-like cells are in-
creased. GATA6 is co-expressed with SPDEF in the same
lineages in the small intestine [4]. Based on these findings
[4], we hypothesized that GATA4/GATA6 regulates crypt
cell proliferation and secretory cell differentiation in the
small intestine by repressing Spdef gene expression. To
test this hypothesis, we defined the functions most likely
regulated by the overlapping GATA6/SPDEF target gene
set in mouse intestine, delineated the relationship between
GATA6 chromatin occupancy and Spdef gene regulation
in Caco-2 cells, and determined the extent to which
prevention of Spdef up-regulation by Spdef knockout
rescues the GATA6 phenotype in conditional Gata6 knock-
out mouse ileum.
Results and discussion
GATA6 and SPDEF regulate similar subsets of genes
To gain insight on the relationship between GATA6 and
SPDEF in the small intestine, we scanned the overlap of
gene targets using publicly available gene profiling data
from conditional Gata6 and Spdef knockout mouse intes-
tine [4,9]. Previously, we identified 2564 genes whose
expression is altered in ileum by conditional Gata6 de-
letion [4]. Network analysis of this gene set indicated
an up-regulation of p53 targets and a down-regulation of
c-MYC targets (Additional file 1: Figure S1), consistent
with a decrease in cellular proliferation. Of the 2564 genes
altered by conditional Gata6 knockout, 83% (2119) were
also altered by Spdef knockout (Figure 1A), a far greater
overlap than would be expected from a similar-sized, ran-
domized allocation of genes (P < 10-60, Fisher’s Exact Test).
The changes in expression of this subset when Gata6 is
deleted were analyzed by gene set array analysis. Using
Database for Annotation, Visualization and Integrated
Discovery (DAVID), we conducted functional annotation
clustering of all the major pathways (listed in the KEGG,
Biocarta and BBID databases). We found that Wnt signal-
ing was the function most likely to be effected (Figure 1B),
consistent with regulation of crypt cell proliferation. Using
Gene Set Enrichment Analysis (GSEA), a publically
available bioinformatics tool that delineates gene expres-
sion data for enrichment of pre-defined gene-sets, APC
target network was one of the top three networks affected
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Figure 1 Overlap of genes in small intestine modulated by conditional Gata6 or Spdef knockout. (A) Publicly available gene profiling data
from conditional Gata6 (GSE22416) and Spdef (GSE14892) knockout mouse intestine show a significant overlap. (B) Functional annotation
clustering of pathways shows that the top-enriched cluster, in overlapping Gata6 and Spdef genes, contains the Wnt pathway as its main function
(ES score 2.58). (C) GSEA analysis shows, in the overlapping Gata6 and Spdef gene segment, APC targets as the second most highly enriched
cluster (ES score 1.57).
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Score (NES) of −1.57 (Figure 1C). This analysis reveals a
very strong overlap in gene targets between GATA6 and
SPDEF, and suggests that the principal function of this
overlap involves cellular proliferation.
GATA6 regulates Spdef gene expression and occupies a
locus in the Spdef 5′-flanking region in human Caco-2 cells
Conditional Gata6 deletion in mice produces an up-
regulation of Spdef gene expression in ileum while knock-
out or over-expression of Spdef has no effect on Gata6
expression [4], suggesting that Spdef is regulated down-
stream by GATA6. To determine the extent to which
this process is conserved, and to further explore the role
of GATA6 in regulating Spdef gene expression, we char-
acterized the effect of Gata6 knock-down on Spdef gene
expression in Caco-2 cells. The Caco-2 cell line is a human
colorectal adenocarcinoma-derived cell line that expresses
GATA6, but very little GATA4 [11], similar to the ileum.We screened five GATA6 short-hairpin RNA (shRNA)
knockdown lentiviral constructs, and found that only one
resulted in a statistically significant knockdown of Gata6
mRNA (55%, P < 0.05, Figure 2A) and a concomitant
decrease in GATA6 protein (Figure 2B). Spdef mRNA
was up-regulated 2-fold in Gata6 knock-down (G6kd)
cells (P < 0.05, Figure 2A), demonstrating that the Caco-2
cells model the up-regulation of Spdef gene expression
observed in conditional Gata6 knockout mouse ileum [4].
To gain insight on the relationship between GATA6 and
Spdef gene expression, we examined GATA6 chromatin
occupancy at the Spdef gene locus. Because we were
unable to immunoprecipitate bound chromatin from
crosslinked mouse intestinal epithelial cells using existing
antisera, we utilized the human Caco-2 intestinal cell
culture model in which GATA6 ChIP assays have been
performed previously [12]. Using a publicly available
GATA6 chromatin immunoprecipitation-high throughput
sequencing (ChIP-seq) database in Caco-2 cells [12], we
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Figure 2 GATA6 regulates Spdef expression and occupies an enhancer in the Spdef 5′-flanking region in Caco-2 cells. (A) Quantitative
RT-PCR analysis showing reduced expression of Gata6 mRNA, and enhanced expression of Spdef mRNA in Caco-2 cells infected with a lentivirus
vector expressing an shRNA for human Gata6 mRNA (G6kd) (mean ± SD, n = 5, *P < 0.05). An shRNA vector for GFP was used as a control (Ctl).
(B) Western analysis showing reduced abundance of GATA6 in G6kd Caco-2 cells. Β-actin was used as an internal loading control. (C) Schematic
representation of the human Spdef 5′-flanking region showing GATA6 occupancy at a locus ~40 kb upstream of the transcription start site (TSS).
GATA6 sequence tag density is shown as a ‘wiggle file’, and a statistically significant GATA6-occupied locus was defined by MACS peak analysis
[29] (dotted box). (D) ChIP assays on chromatin obtained from Caco-2 cells using a GATA6 antibody and three sets of overlapping primers centered on
the GATA motif showing increased GATA6 occupancy (mean ± SD, n = 4, *P < 0.05). The salivary amylase-α1a (Amy-1) TSS was used as a negative
control. ChIP assays using anti-rabbit IgG was used as a control for non-specific immunoprecipitation and primer efficiency.
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proximately 40 kb upstream of the Spdef transcription
start site (TSS) that mapped to the Spdef gene based on
closest distance to any TSS (Figure 2C). To confirm and
localize GATA6 occupancy at this locus, we performed
GATA6 ChIP assays using a multiple, overlapping primer
strategy with amplicons of ~200 bp per primer pair
(Figure 2C) centered at the only GATA motif within
this region. We found increases of all three amplicons with
amplicon from primer set 2 being significantly greater
(~70%, P < 0.05, n = 4) than the Amy1 TSS negative control
(Figure 2D). Although our ChIP data reveal a modest in-
crease in enrichment, it is nonetheless statistically signifi-
cant and thus confirmatory of ChIP-seq data conducted
by others [12] (see MACS peak data, Figure 2C). We
also conducted an IgG control ChIP assay to show that
enrichment with primer set 2 was not due to differences
in primer efficiency from that of the Amy1 TSS, or to
non-specific antibody binding (Figure 2D). These data
confirm previous ChIP-seq analysis that GATA6 occupies
a cis-regulatory region that maps to the Spdef gene [12],
and, together with Spdef up-regulation in G6kd cells, is
consistent with the notion that GATA6 directly represses
Spdef gene transcription. While mapping of occupancy
sites to the nearest TSS is a well recognized method for
defining transcription factor targets on a global basis
[12,13], direct regulation of Spdef gene expression by
GATA6 at this site will need to be confirmed using chromo-
some conformation capture or other techniques [14].
Transcriptional repression is highly complex, especially in
eukaryotes, generally involving the recruitment of specific
co-repressors and the local modification of histone tails and
chromatin structure [15]. GATA factors are well known to
mediate gene repression, and the mechanisms are begin-
ning to be understood. GATA4 has been shown to directly
repress cardiac genes [16] while GATA1 has been shown
to directly repress hematopoietic genes [17,18]. Both
GATA4 and GATA1 interact directly with corepressor
complexes including the nucleosome remodeling and his-
tone deacetylase (NuRD) complex and the polycomb
repressive complex 2 (PRC2) [16], and are necessary
for the multiple modifications of histone tails, but the
extent to which GATA factors recruit co-repressors and/
or modulate histone tails in the small intestine remains to
be determined.
Spdef knockout rescues the proliferation defect in
conditional Gata6 knockout mice
We next asked to what extent Spdef deletion rescues the
conditional Gata6 knockout phenotype by analyzing single
and double Gata6/Spdef knockout mice. In previous
studies, conditional deletion of Gata6 [4] or deletion of
Spdef [9] resulted in greatly diminished levels of Gata6 or
Spdef mRNA, respectively, in the intestine that correlatedwith reduced protein levels and altered intestinal pheno-
types. Analysis of mRNA in the present study showed that
Gata6 and Spdef mRNAs were both expressed in Ctl mice,
Gata6 mRNA was nearly undetectable while Spdef mRNA
was expressed in Gata6ΔIE mice, Gata6 mRNA was
expressed while Spdef mRNA was nearly undetectable
in SpdefKO mice, and both Gata6 and Spdef mRNAs were
nearly undetectable in the double knockout (DKO) mice
(Additional file 1: Figure S2), verifying our models.
Crypt cell proliferation is essential for the continuation
of intestinal epithelial renewal. One of the principal pheno-
typic outcomes of conditional Gata4/Gata6 deletion is
a ~30% reduction in the number of Ki67- and BrdU-positive
cells, and a concomitant decrease in villus height and vil-
lus epithelial cell number [4] resulting in a reduction in
absorptive surface area. To define the role of SPDEF in
mediating the decrease in crypt cell proliferation when
Gata6 is conditionally deleted, we stained ileal segments
for Ki67 and BrdU (Figure 3A), markers of the non-G0
and S-phases of the cell cycle, respectively. The number of
Ki67-positive and BrdU-positive crypt cells was signifi-
cantly reduced ~40% in Gata6ΔIE mice (Figure 3B), as
previously reported [4], but unchanged in SpdefKO mice,
as compared to controls. The number of Ki67- and
BrdU-positive crypt cells in DKO mice was also similar
to controls, indicating that the additional deletion of
Spdef rescues the decrease in crypt cell proliferation
observed in Gata6ΔIE mice. These data support the notion
that GATA6 maintains crypt cell proliferation by down-
regulating Spdef gene expression.
SPDEF does not regulate the secretory cell differentiation
function of GATA6
Previously, conditional deletion of Gata6 in the ileum
resulted in a 25-40% reduction in the number of chromo-
granin A (CHGA)-positive cells, and in the mRNA abun-
dances of Chga and Neurog3 [4], consistent with a decrease
in enteroendocrine lineage commitment. Though not sta-
tistically significant, we found a 15-50% reduction in the
number of CHGA-positive cells (Figure 4A), and in the
mRNA abundances of Chga and Neurog3 (Figure 4B) in the
Gata6ΔIE mice, in general agreement with our previous
study [4]. We further found that although the pattern for
these three measurements in the SpdefKO mice was similar
to that in Ctl mice, consistent with previous data for distal
intestine [9], the pattern in the DKO mice was similar to
that in the Gata6ΔIE mice (Figure 4A and B). Together,
these data show that enteroendocrine cell commitment
is reduced in both Gata6ΔIE and DKO mice, indicating
that GATA6 promotes enteroendocrine cell commitment
independently of SPDEF.
Previously, we also showed that conditional Gata6
deletion resulted in a transformation of Paneth cells into
Mucin-2 (MUC2)-enriched goblet-like cells at the base of
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http://www.biomedcentral.com/1471-2199/15/3crypts [4]. In the present study, immunostaining for
CRS4C, a Paneth-specific marker, was slightly reduced
in SpdefKO mice as compared to controls, consistent
with previous data [9], but was greatly reduced in both
Gata6ΔIE and DKO mice as compared to controls
(Figure 5A). The number of crypt cross-sections with
at least one CRS4C-positive cell was nearly 100% in Ctl
and SpdefKO mice, but was less than 30% in both
Gata6ΔIE and DKO mice (P < 0.01 for each, Figure 5B).CHGA-positive cells
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cells, as previously shown [9], and similar to controls in
DKO mice (Figure 5A). MUC2 immunostaining was greatlymRNA abundance Neurog mRNA abundance
0
1
2
3
DKO mice. (A) Quantification of CHGA-positive cells in each group.
1000 epithelial cells was determined as described in Methods. (B) Chga
d generally lower numbers of CHGA-positive cells and Chga and
teroendocrine lineage allocation.
Ctl
CR
S4
C
Gata6ΔIE SpdefKO DKO
PA
S
M
UC
2
P<0.01
P<0.01
P<0.01 P<0.01
0
0.5
1.0
1.5
CRS4C-positive crypts
CR
S4
C-
po
sit
ive
 c
ry
pt
s/
to
ta
l n
um
be
r o
f c
ry
pt
s 
m
R
N
A 
ab
un
da
nc
e 
(re
lat
ive
 to
 co
ntr
ol) P<0.05
P<0.01
P<0.01
0
2
4
6
Lyz mRNA abundance
0
1
2
3
4
5
Muc2 mRNA abundance
A
B C
Figure 5 Paneth cells are decreased in Gata6ΔIE and DKO mice. (A) Immunostaining in ileum for CRS4C (first row) and MUC2 (third row), and
chemical staining using the PAS reaction (second row). (B) Quantification of CRS4C-positive cells in each group. Sections of ileum were stained for
CRS4C, and the number of positive cells/crypt cross section was determined as described in Methods. (C) Lyz and Muc2 mRNA abundance in each
group. Gata6ΔIE and DKO mice had significantly lower numbers of CRS4C-positive cells and Lyz mRNA abundance than Ctl mice, consistent with
a decrease in mature Paneth cells.
Aronson et al. BMC Molecular Biology 2014, 15:3 Page 7 of 12
http://www.biomedcentral.com/1471-2199/15/3enriched in crypts of Gata6ΔIE mice, consistent with our
previous report [4], but similar to controls in SpdefKO and
DKO mice (Figure 5A). Generally consistent with this
observation, Muc2 mRNA abundance in Gata6ΔIE mice
was 2.5-fold higher as compared to controls, though not
statistically significant, whereas Muc2 mRNA abundances
in SpdefKO and DKO mice were similar to controls
(Figure 5C). These data indicate that the additional dele-
tion of Spdef did not rescue the decrease in the terminal
differentiation of Paneth cells observed in Gata6ΔIE
mice, but did at least partially prevent their conversion
to MUC2-enriched goblet-like cells. Thus, SPDEF is notnecessary for the GATA-mediated differentiation of Paneth
cells, but does function in their default differentiation into
goblet-like cells in the absence of Gata6. This is consistent
with the general function of SPDEF to promote the differ-
entiation of goblet cells [9,10].
In spite of the common secretory cell phenotypes in
Gata6 deletion and Spdef over-expression models [4,10],
our data show that Spdef deletion did not rescue the Gata6
knockout defects in enteroendocrine lineage commitment
or in Paneth cell differentiation. Closer scrutiny suggests
that the secretory cell phenotypes in the Gata6 deletion
and Spdef over-expression models are not identical. While
Aronson et al. BMC Molecular Biology 2014, 15:3 Page 8 of 12
http://www.biomedcentral.com/1471-2199/15/3the decline in enteroendocrine and Paneth cells, and accu-
mulation of goblet cells, appear similar, the underlying
alteration in Paneth and goblet cell differentiation is
different. Conditional Gata6 deletion has no effect on
the normal commitment and differentiation of goblet
cells on villi but reveals a conversion of Paneth cells at
the base of crypts into a goblet-like cell type. These cells
do not express defensins, but express abundant Muc2;
they also express abundant Sox9 and Ephb3 [4], indicating
that they are committed and targeted Paneth cells. On the
other hand, conditional Spdef over-expression results in a
generalized increase in goblet cells at the expense of all
other epithelial cell types [10]. Hence, these mice show a
decline in Paneth cell specification rather than a defect in
the terminal differentiation of committed Paneth cells, as
observed in our conditional Gata6 knockout model.SPDEF does not regulate the absorptive enterocyte gene
expression function of GATA6
We next examined whether Spdef loss affected GATA6-
dependent absorptive enterocyte gene expression. Condi-
tional Gata6 deletion resulted in a down-regulation of
specific absorptive enterocyte genes in ileum that in-
clude lipid transporters and apolipoproteins, and an up-
regulation of genes in absorptive enterocytes normally not
expressed or expressed at low levels in small intestine, but
expressed at high levels in colon [4]. Using marker genes
for these two patterns, apolipoprotein A1 (Apoa1) and
carbonic anyhdrase 1 (Car1), respectively, we found that
their mRNA abundances were down-regulated and up-
regulated, respectively, in Gata6ΔIE mice (Figure 6),
consistent with our previous findings [4]. Apoa1 and
Car1 mRNA abundance in SpdefKO mice was similar
to controls, whereas that in DKO mice was similar to
Gata6ΔIE, indicating that SPDEF does not play a rolem
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Figure 6 Absorptive enterocyte gene expression is altered in Gata6Δ
Apoa1, and significantly higher Car1 mRNA abundances than Ctl mice.in mediating the conditional Gata6 knockout alteration in
absorptive enterocyte gene expression.
GATA6 is expressed in crypts and in mature absorptive
enterocytes [4,5], whereas SPDEF is expressed in secretory
progenitors, and in goblet and Paneth cells, but is not
expressed in mature absorptive enterocytes [9,10]. While
it is possible that SPDEF could instruct gene expression in
absorptive enterocytes through a process that originates in
progenitors early in the differentiation process, we found
that SPDEF did not regulate the GATA6 targets studied
here. As in the GATA4-specific pathway, in which GATA4
regulates its targets in mature absorptive enterocytes on
villi rather than in crypt progenitors [19], we believe that
GATA6 also regulates absorptive enterocyte gene expres-
sion within mature absorptive enterocytes on villi.Conclusion
Previously, we defined two fundamental pathways of GATA
regulation in the small intestine, one mediated exclusively
by GATA4 (GATA4-specific pathway), and one regulated
by GATA4 or GATA6 (GATA4/GATA6-redundant path-
way) (Figure 7). In the GATA4-specific pathway, GATA4,
but not GATA6, activates and represses a subset of absorp-
tive enterocyte genes, and by virtue of its expression in the
proximal 85% of small intestine and lack of expression in
distal ileum [7], distinguishes proximal intestinal from distal
ileal gene expression and function [5,7,8]. For the GATA4/
GATA6-redundant pathway, either GATA4 or GATA6
(which is expressed throughout the small intestine, includ-
ing distal ileum) promote intestinal epithelial renewal by
supporting crypt cell proliferation, enteroendocrine lineage
commitment, Paneth cell differentiation, and absorptive
enterocyte gene expression [4]. Here, we show that the
maintenance of crypt cell proliferation function of the
intestinal GATA4/GATA6-redundant pathway is dependentCar1 mRNA abundance
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absorptive enterocyte genes (GATA4-specific), whereas either GATA4 or
GATA6 (purple/blue) promote crypt cell proliferation, enteroendocrine
lineage commitment, Paneth cell differentiation, and absorptive
enterocyte gene expression (GATA4/GATA6-redundant). GATA4/GATA6
promotes the crypt cell proliferation function by repressing the gene
encoding SPDEF (green).
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http://www.biomedcentral.com/1471-2199/15/3on SPDEF (Figure 7). Specifically, our data support the
notion that GATA4/GATA6 promotes crypt cell prolifera-
tion by directly repressing Spdef gene expression.
GATA6 has been suggested to be oncogenic in multiple
cancers and pre-cancerous lesions, including Barrett’s
esophagus, gastric cancer, pancreatic cancer, and colon
cancer [20]. Gata6 expression is up-regulated in colon
cancer epithelial cells [21-23], as well as in non-malignant
cells along the stromal margins in human colorectal cancer
[22], but it should be noted that it has not been determined
whether this is a correlative, causative or protective event.
Recently, Noah et al. [24] showed that SPDEF functions as
a colorectal tumor suppressor. In colorectal tumors from
patients, loss of SPDEF was observed in approximately 85%
of tumors and correlated with progression from normal
tissue, to adenoma, to adenocarcinoma. Further, SPDEF
inhibited the expression of β-catenin-target genes in mouse
colon tumors, and interacted with β-catenin to block its
transcriptional activity in colorectal cancer cell lines,
resulting in lower levels of cyclin D1 and c-MYC. Pathway
analysis showed that Gata6 deletion also modulatedc-MYC targets (Additional file 1: Figure S1) and that the
GATA6/SPDEF overlapping gene set likely functions in
Wnt signaling (Figure 1). Thus, our data here suggest
that the possible tumorigenic effects of GATA6 could
be mediated by its repression of Spdef gene expression.
Methods
Analysis of publicly available gene profiling data
From the National Center for Biotechnology Information
(NCBI) website (http://www.ncbi.nlm.nih.gov/), we down-
loaded gene profiling data from the ileum of conditional
Gata6 knockout mice (GSE22416) [4], and from the small
intestine of Spdef−/− mice (GSE14892) [9]. Data analysis
was performed using Cistrome (www.cistrome.org), a flex-
ible bioinformatics workbench with an analysis platform
for ChIP-seq and gene expression microarray analysis [25].
Significant over-representation of overlapping target genes
was determined by the Fisher’s Exact Test. Gene ontology
analysis and pathway analysis was conducted using Data-
base for Annotation, Visualization and Integrated Discovery
(DAVID) [26]. Gene set enrichment analysis was performed
by using publicly available Gene Set Enrichment Analysis
(GSEA) tools v2.3 from the Broad Institute [27].
Cell culture and lentiviral infection
Lentiviral infection was conducted as previously de-
scribed [28]. 293 T and Caco-2 cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Mediatech,
Inc., Manassas, VA) containing glucose (4.5 g/liter),
l-glutamine, and sodium pyruvate. The media was supple-
mented with 10% fetal bovine serum (Atlanta Biologicals,
Lawrenceville, GA) and penicillin (100 U/ml)-streptomycin
(1 mg/ml) (Sigma Chemical Company, St. Louis, MO).
Both cell lines were maintained in 5% CO2 at 95% relative
humidity and 37°C. Media were replaced every 2 to 3 days.
To produce lentivirus for the knockdown of Gata6, 293 T
cells were plated at 105 cells/ml on 6-cm plates and trans-
fected after 24 h with 1 μg of vesicular stomatitis virus
glycoprotein G (VSV-G) envelope-expressing plasmid pMD.
G, 1 μg of pCMV-dR8.91 (Delta 8.9) plasmid containing
gag, pol, and rev genes, and 1 μg of shRNA-pLKO.1
plasmids expressing a knockdown short hairpin RNA
(shRNA) (Sigma) for green fluorescent protein (GFP)
(used as a control [Ctl]) (SHC005) or human Gata6
(G6kd) using 6 μl of FuGENE 6 reagent (Roche Diagnostic
Corporation, Indianapolis, IN). A total of five human
Gata6 knockdown constructs were screened, and only one
(TRCN0000005392) was subsequently found to reduce
Gata6 mRNA significantly. Media from the transfected
293 T cells were changed 16 h after transfection. Culture
media containing lentiviral particles were collected and
filtered (0.45 μm pore size) 48 h after transfection and
transferred immediately to Caco-2 cells plated at 30% con-
fluence to infect for 2 h using 0.5 μl of polybrene/ml.
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infected cells using 4 μg/ml puromycin. Infected cells were
kept under conditions of selection until the day of har-
vesting. Trypsinized cells were homogenized using a QIA
shredder (Qiagen, Inc., Valencia, CA), and RNA was iso-
lated as described above for mouse tissue. Nuclear extracts
were isolated as described previously [11]. Gata6 knock-
down was determined by quantitative reverse transcriptase-
(qRT-) PCR for human Gata6 (see Additional file 1:
Figure S3A for primers) and by Western blot analysis as
previously described [5] using rabbit anti-GATA6 (Cell
Signaling Technology, Inc, Danvers, MA; Cat. No. 4253S).
Chromosomal immunoprecipitation (ChIP) assays
Using a publicly available GATA6 chromatin immunopre-
cipitation-high throughput sequencing (ChIP-seq) database
in Caco-2 cells [12], sequences were mapped to reference
genome Homo Sapiens build 18 (HG18) using ELAND
tools, allowing 0 to 2 mismatches (Illumina), and binding
peaks were identified by model-based analysis of ChIP-seq
(MACS) [29] using default parameters and P value cutoffs
of 10-10.
Chromosomal immunoprecipitation (ChIP) assays were
conducted as previously described [28]. Caco-2 cells were
incubated in DMEM containing 1% formaldehyde (Fisher
Scientific, Pittsburgh, PA) for 10 min at 37°C. The cells
were washed 2 times with PBS, scraped, and resuspended
in lysis buffer (50 mM Tris-Cl [pH 8.1], 10 mM EDTA,
1% sodium dodecyl sulfate [SDS]) containing protease in-
hibitor cocktail and PMSF (10 μl/ml). The samples were
sonicated to obtain chromatin fragments of between 400
and 1,000 bp. Sonicated samples were resuspended in
ChIP dilution buffer (1% Triton X-100, 2 mM EDTA,
150 mM NaCl, 20 mM Tris–HCl, pH 8.1) and incubated
overnight at 4°C with Dynabeads beads (Life Technologies,
Grand Island, NY) conjugated with rabbit anti-GATA6
(Cell Signaling; Cat. No. 4253) or rabbit IgG (negative
control) (Millipore, Temecula, CA; Cat. No. PP64B). The
IP samples were washed 6 times with radioimmunopreci-
pitation (RIPA) buffer (50 mM HEPES [pH 7.6], 0.5 M
LiCl, 1 mM EDTA, 1% Nonidet P-40, 0.7% sodium
deoxycholate), and the DNA was recovered by reverse
cross-linking in 1% SDS–0.1 M NaHCO3 for 7 h at 65°C.
DNA was purified using a QIAquick PCR purification kit
(Qiagen) and quantified by Picogreen (Life Technologies).
One nanogram of DNA was used per qPCR reaction using
primers shown in Additional file 1: Figure S3B.
Mice
Previously established and confirmed Gata6loxP/loxP [30],
Spdef−/− [9], and transgenic VillinCreERT2 [31] mice were
used in this study to produce four groups of mice, including
controls (Ctl), conditional Gata6 deletion in the intes-
tinal epithelium (Gata6ΔIE), germline Spdef knockout(SpdefKO), and double Gata6/Spdef knockout (DKO).
The genotypes of each group are as follows:
Ctl: Gata6loxP/loxP, Spdef +/−, VillinCreERT2-negative
Gata6ΔIE: Gata6loxP/loxP, Spdef +/−, VillinCreERT2-positive
SpdefKO: Gata6loxP/loxP, Spdef −/−, VillinCreERT2-negative
DKO: Gata6loxP/loxP, Spdef −/−, VillinCreERT2-positive
DNA was extracted from tail biopsies, and genotypes
were determined by semiquantitive polymerase chain reac-
tion (PCR) using previously validated primers (Additional
file 1: Figure S3C). Male and female mice four weeks of age
were treated with a single dose of tamoxifen (Sigma)
(0.1 ml, 10 mg/ml; dissolved in ethanol/sunflower oil = 1:9
[vol/vol]) daily for five consecutive days as described [5],
followed by a single dose two weeks later (see timeline,
Additional file 1: Figure S4). Mice were killed and tissue
was collected 28 days after the start of tamoxifen treat-
ment. Bromodeoxyuridine (BrdU, 0.1 ml of 10 mg/ml)
was injected two hours before dissection. Approval was
obtained from the Institutional Animal Care and Use
Committee.Tissue isolation and processing
Mice were anesthetized for dissection as previously de-
scribed [28]. The most distal 1.0 cm segment of small
intestine adjacent to the ileocecal valve was snap frozen
for RNA isolation, and the 6 cm segment proximal to that
was removed and transferred to a glass plate on wet ice
and prepared for sectioning. This segment was flushed
with ice cold 4% paraformaldehyde (PFA) in PBS, cut
longitudinally, pinned open onto paraffin wax in a petri
dish filled with 4% PFA in PBS with the epithelium facing
upward. After a 5 min incubation period, the pins were
removed and the proximal end was grasped with forceps,
rolled with the epithelium facing outwards, and a pin was
inserted transversely to secure the roll in place. The roll
was placed in 10 ml of 4% PFA in PBS and mixed gently
on a tube rotator for 16–18 hr at 4°C. The PFA was
decanted and the tissue was washed in PBS 3 times for
20 min each at 4°C, and then dehydrated in 70% ethanol.
Tissue was processed at the Rodent Histopathology Core
at the Dana Farber/Harvard Cancer Center (Boston, MA)
for paraffin embedding and sectioning. Selected slides
were stained using the periodic acid Schiff (PAS) reaction.RNA isolation and gene expression analysis
RNA was isolated using the RNeasy kit (Qiagen), and
mRNA abundances were determined by qRT-PCR as
previously described [4], using validated primer pairs
(Additional file 1: Figure S3A). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA abundance was measured
for each sample and used to normalize the data. Data were
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minimum of five mice in each group was analyzed.
Immunohistochemistry
Tissue sections were immunostained as previously de-
scribed [28]. Primary antibodies included rabbit anti-Ki67
(Thermo Fisher Scientific, Inc., Fremont, CA; Cat. No. RM-
9106-S1) (1:200), mouse anti-BrdU (Thermo; Cat. No.
MS-1058-PO) (1:250), goat anti-cryptdin related sequence
4C (CRS4C) (gift from Dr. A. J. Ouellette, University of
Southern California, Los Angeles, CA) [32] (1:2000), and
rabbit anti-MUC2 (Santa Cruz Biotechnology, Inc, Santa
Cruz, CA; Cat. No. sc15334) (1:100). Secondary antibodies
included biotinylated donkey anti-rabbit IgG, donkey
anti-goat IgG, and donkey anti-mouse IgG (all from
Vector Labs, Burlingame, CA). Biotinylated antibodies were
linked to avidin-horseradish peroxidase conjugates (Vector
Labs), visualized using 3,3′-diamino benzidine (Sigma) for
2 to 5 min, and lightly counterstained with hematoxylin.
Cell counting
The total number of Ki67-, BrdU-, or CRS4C-positive cells
in crypts was determined as the total number per crypt.
Only well oriented crypts with the epithelial layer on at
least one side continuous with the villus epithelial layer
were counted, and a minimum of 6 crypts per slide were
analyzed. The average number of CHGA–positive cells
was expressed as a fraction of total epithelial cells (villi
and crypts) from a minimum of 5000 epithelial cells per
slide, with equal representation of crypts and villi. All de-
terminations were blinded and conducted on a minimum
of 5 animals per group.
Statistical analyses
In Caco-2 cells, qRT-PCR data was compared by the
student’s t-test and ChIP data were compared by the ana-
lysis of variance (ANOVA) followed by the Tukey-Kramer
multiple comparison test. In mice, mRNA measurements
had unequal variances across groups requiring nonparamet-
ric statistics, and were thus compared by the Kruskal-Wallis
test followed by the Dunn multiple comparison test, and
presented as individual data points and medians. Cell count
determinations had equal variances across groups allowing
parametric statistics, and were thus compared by ANOVA
followed by the Tukey-Kramer multiple comparison test,
and presented as mean ± SD. Differences were considered
statistically significant at a P-value of less than 0.05.
Additional file
Additional file 1: Figure S1. Intestinal Gata6 deletion alters gene
networks controlling cell proliferation in the mature ileum. Network
analyses on microarray data of Ctl and Gata6ΔIE ileum (n=3 in each
group) revealed (A) an increase in targets of the tumor surpressor genep53, and (B) a decrease in targets of the proto-oncogene c-MYC. (C)
Legend defining symbols used in the networks. Arrows indicate the direction
of the interaction. Red circles = up-regulated transcripts; Blue circles = down-
regulated transcripts. Differentially expressed transcripts were determined at
the 5% FDR level using Significance Analysis of Microarrays (SAM) and
interaction networks were developed from the differentially expressed
transcripts using Metacore. Figure S2. Gata6 and Spdef mRNA abundance
in ileum in each group of mice. Gata6ΔIE and DKO mice had significantly
lower Gata6 mRNA abundances than Ctl and SpdefKO mice. SpdefKO and
DKO mice had significantly lower Spdef mRNA abundances than Ctl and
Gata6ΔIE mice. Figure S3. Primers used for: (A) qRT-PCR, (B) ChIP assays, and
(C) genotyping. Figure S4. Timeline for study. Mice 4 wks of age were given
Tamoxifen as indicated (black circle) beginning on Day 0, and an
injection of BrdU 2 hr before tissue collection at Day 28.
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